Chowdary, P;
Nathwani, A;
(2022)
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B: The authors reply.
New England Journal of Medicine
, 387
(14)
pp. 1336-1337.
10.1056/NEJMc2210918.
Preview |
Text
nejmc2210918.pdf - Published Version Download (312kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B: The authors reply |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1056/NEJMc2210918 |
| Publisher version: | https://doi.org/10.1056/NEJMc2210918 |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher's terms and conditions. |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10158127 |
Downloads since deposit
15Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
